Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Sbi Alapharma Canada, Inc.

Clinical trials sponsored by Sbi Alapharma Canada, Inc., explained in plain language.

Now part of SBI Holdings, Inc. 8473 TOKYO

Canadian subsidiary of Sumitomo Chemical, involved in pharmaceutical development.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Glow-in-the-Dark drug could slash repeat breast cancer surgeries

Disease control Terminated

This phase 3 trial tested a drug called PD G 506 A that makes cancer cells glow under a special camera during breast-conserving surgery. The goal was to help surgeons see and remove leftover cancer in real time, reducing the need for a second operation. The study enrolled 57 wome…

Phase: PHASE3 • Sponsor: SBI ALApharma Canada, Inc. • Aim: Disease control

Last updated Jun 26, 2026 12:47 UTC